Page 1 | Search Results | The Journal of Immunology | American Association of Immunologists

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

M. Christian Tjiam, James P. A. Taylor, Mazmah A. Morshidi, Lucy Sariputra, Sally Burrows, Jeffrey N. Martin, Steven G. Deeks, Dino B. A. Tan, Silvia Lee, Sonia Fernandez, Martyn A. French

J Immunol (2015) 194 (11): 5320–5328.

https://doi.org/10.4049/jimmunol.1402918

Published: 01 June 2015

View articletitled, Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

Add to Citation Manager for Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

Includes: Supplementary data

Journal Articles

Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.

B R Blazar, M K Jenkins, P A Taylor, J White, A Panoskaltsis-Mortari, R Korngold, D A Vallera

J Immunol (1997) 159 (12): 5821–5833.

https://doi.org/10.4049/jimmunol.159.12.5821

Published: 15 December 1997

View articletitled, Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.

Add to Citation Manager for Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.

Journal Articles

CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.

B R Blazar, P A Taylor, M W Boyer, A Panoskaltsis-Mortari, J P Allison, D A Vallera

J Immunol (1997) 159 (7): 3460–3473.

https://doi.org/10.4049/jimmunol.159.7.3460

Published: 01 October 1997

View articletitled, CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.

Add to Citation Manager for CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.

Journal Articles

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

B R Blazar, P A Taylor, A Panoskaltsis-Mortari, J Buhlman, J Xu, R A Flavell, R Korngold, R Noelle, D A Vallera

J Immunol (1997) 158 (1): 29–39.

https://doi.org/10.4049/jimmunol.158.1.29

Published: 01 January 1997

View articletitled, Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

Add to Citation Manager for Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

Journal Articles

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

B R Blazar, A H Sharpe, P A Taylor, A Panoskaltsis-Mortari, G S Gray, R Korngold, D A Vallera

J Immunol (1996) 157 (8): 3250–3259.

https://doi.org/10.4049/jimmunol.157.8.3250

Published: 15 October 1996

View articletitled, Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

Add to Citation Manager for Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

Journal Articles

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

B R Blazar, P A Taylor, W E Fitzsimmons, D A Vallera

J Immunol (1994) 153 (4): 1836–1846.

https://doi.org/10.4049/jimmunol.153.4.1836

Published: 15 August 1994

View articletitled, FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

Add to Citation Manager for FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

Journal Articles

In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.

B R Blazar, P A Taylor, D A Vallera

J Immunol (1994) 152 (7): 3665–3674.

https://doi.org/10.4049/jimmunol.152.7.3665

Published: 01 April 1994

View articletitled, In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.

Add to Citation Manager for In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.

Journal Articles

Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.

B R Blazar, P A Taylor, D C Snover, S N Sehgal, D A Vallera

J Immunol (1993) 151 (10): 5726–5741.

https://doi.org/10.4049/jimmunol.151.10.5726

Published: 15 November 1993

View articletitled, Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.

Add to Citation Manager for Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.

Journal Articles

Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.

B R Blazar, P A Taylor, D C Snover, J A Bluestone, D A Vallera

J Immunol (1993) 150 (1): 265–277.

https://doi.org/10.4049/jimmunol.150.1.265

Published: 01 January 1993

View articletitled, Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.

Add to Citation Manager for Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.

Journal Articles

Further Studies on the Identification of the Subcomponents of the First Component of Complement After Affinity Chromatography of Human Serum on IgG-Sepharose

P. A. Taylor, S. Fink, D. H. Bing, R. H. Painter

J Immunol (1977) 118 (5): 1722–1727.

https://doi.org/10.4049/jimmunol.118.5.1722

Published: 01 May 1977

View articletitled, Further Studies on the Identification of the Subcomponents of the First Component of Complement After Affinity Chromatography of Human Serum on IgG-Sepharose

Add to Citation Manager for Further Studies on the Identification of the Subcomponents of the First Component of Complement After Affinity Chromatography of Human Serum on IgG-Sepharose

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.

CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.

In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.

Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.

Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.

Further Studies on the Identification of the Subcomponents of the First Component of Complement After Affinity Chromatography of Human Serum on IgG-Sepharose

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

Update search

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only